Article metrics

Extended report
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study

 

Online download statistics by month:

Online download statistics by month: January 2013 to September 2020

AbstractFullPdf
Jan 2013726292395
Feb 2013304216199
Mar 2013235622319
Apr 2013139201110
May 201372259138
Jun 201355262109
Jul 20134921178
Aug 20135025684
Sep 20135325862
Oct 20135130680
Nov 20134736880
Dec 2013796263235
Jan 2014483281203
Feb 2014268228173
Mar 2014262299122
Apr 2014180248111
May 201412224292
Jun 201411317981
Jul 201429521882
Aug 201412238869
Sep 201410025893
Oct 201410032369
Nov 20145824793
Dec 20148821770
Jan 20157822959
Feb 20156924854
Mar 20156326884
Apr 20155420070
May 20156920979
Jun 20158525981
Jul 20156627495
Aug 20155011248
Sep 20157814541
Oct 2015335626
Nov 2015458046
Dec 2015488227
Jan 2016828339
Feb 2016348629
Mar 2016287751
Apr 2016318544
May 2016568842
Jun 2016417534
Jul 2016366938
Aug 2016506744
Sep 2016507242
Oct 2016527337
Nov 2016615931
Dec 2016447223
Jan 2017647021
Feb 2017275920
Mar 2017246138
Apr 2017166314
May 2017116027
Jun 2017336029
Jul 2017946632
Aug 2017130769
Sep 20171108616
Oct 2017977213
Nov 20171138323
Dec 201731329111
Jan 201822718821
Feb 201815712522
Mar 201813912424
Apr 201818615030
May 2018112917
Jun 2018797315
Jul 20181028813
Aug 2018887618
Sep 2018615317
Oct 201812111135
Nov 201815715536
Dec 201814313912
Jan 2019828028
Feb 2019857423
Mar 2019575124
Apr 2019785620
May 2019514421
Jun 2019523821
Jul 2019605214
Aug 2019735924
Sep 2019836121
Oct 2019825923
Nov 2019504213
Dec 2019806422
Jan 2020856237
Feb 2020625127
Mar 2020615519
Apr 2020695917
May 2020675519
Jun 2020363220
Jul 2020705123
Aug 2020282421
Sep 2020554818
Total10041132475269